Secretin for refractory schizophrenia
- 1 February 2004
- journal article
- clinical trial
- Published by Elsevier in Schizophrenia Research
- Vol. 66 (2-3) , 177-181
- https://doi.org/10.1016/s0920-9964(03)00068-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effects of Intravenous Secretin on Language and Behavior of Children With Autism and Gastrointestinal Symptoms: A Single-Blinded, Open-Label Pilot StudyPublished by American Academy of Pediatrics (AAP) ,2001
- Multisite, Double-Blind, Placebo-Controlled Trial of Porcine Secretin in AutismJournal of the American Academy of Child & Adolescent Psychiatry, 2001
- Repeated Doses of Porcine Secretin in the Treatment of Autism: A Randomized, Placebo-Controlled TrialPediatrics, 2001
- A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autismThe Journal of Pediatrics, 2001
- Effect of secretin on children with autism: a randomized controlled trialDevelopmental Medicine and Child Neurology, 2000
- The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activityProceedings of the National Academy of Sciences, 1998
- [Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenicsJournal of Psychiatric Research, 1997
- Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortexBiological Psychiatry, 1996
- Antipsychotic Effects of Ceruletide (Caerulein) on Chronic SchizophreniaArchives of General Psychiatry, 1982